Vertex

Vertex begins human testing for diabetes cell therapy
Vertex begins human testing for diabetes cell therapy
BioPharma Dive
Vertex
type 1 diabetes
cell therapy
VX-880
Flag link:
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
BioPharma Dive
CRISPR
gene therapy
beta thalassemia
sickle cell disease
CRISPR Therapeutics
Vertex
Bluebird Bio
EHA
Flag link:
Vertex’s Cystic-Fibrosis Drug Faces Big Test
Vertex’s Cystic-Fibrosis Drug Faces Big Test
WSJ Online
Vertex
cystic fibrosis
FDA
Orkambi
Flag link:
The top 10 most expensive drugs of 2013
The top 10 most expensive drugs of 2013
Fierce Pharma
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Flag link:
Biotech Stocks Get Turbo Boost From Idenix Deal
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
Flag link:
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Seeking Alpha
Gilead Sciences
hepatitis C
Merck
Sovaldi
Vertex
Flag link:
Vertex Cystic Fibrosis Trial Has Good, Bad News
Vertex Cystic Fibrosis Trial Has Good, Bad News
Investors.com
Vertex
cystic fibrosis
Kalydeco
Flag link:
Vertex Building A Fortress In Cystic Fibrosis
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Vertex
cystic fibrosis
Gilead
GSK
Kalydeco
Bristol-Myers Squibb
Flag link:
Inside HCV: An Interview with Janssen
Inside HCV: An Interview with Janssen
Motley Fool
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
Flag link:
Vertex strengthens warning with hepatitis C drug
Vertex strengthens warning with hepatitis C drug
Reuters
Vertex
hepatitis C
Incivek
Flag link:
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Vertex
Janssen
hepatitis C
simeprevir
VX-135
Flag link:
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
cataracts
FDA
cystic fibrosis
Vertex
Kalydeco
Flag link:
Hepatitis C testing may lift Vertex’s market
Hepatitis C testing may lift Vertex’s market
The Boston Globe, MA
hepatitis C
Vertex
Incivek
Flag link:
An Assault On Vertex, Enthusiasm Building Around Xoma
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Xoma
Vertex
Flag link:
Vertex Could Fly High on Cystic Fibrosis Projects
Vertex Could Fly High on Cystic Fibrosis Projects
Motley Fool
cystic fibrosis
Vertex
Flag link:
Vertex's Cystic Fibrosis Drug Impresses Investors
Vertex's Cystic Fibrosis Drug Impresses Investors
Seeking Alpha
Vertex
cystic fibrosis
VX-809
Kalydeco
Flag link:
Vertex Is Ready To Rise On INCIVEK Success
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Incivek
Vertex
hepatitis C
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Flag link:
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
cystic fibrosis
Vertex
Gilead
Bristol-Myers Squibb
Indenix
Kalydeco
VX-809
Flag link:
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Flag link:
J&J Open to Expanding Hepatitis C Collaboration With Vertex
J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
hepatitis C
JNJ
Vertex
Flag link:

Pages